increased in a variety of acute stresses, indicating an important role of TSPO in stress response [6] . A recent report and our previous study illustrated that its activation during myocardial ischaemia contributed to arrhythmogensis [9, 10] .
In this study, it has been suggested that chronic intermittent hypobaric hypoxia (CIHH) training might exert an influence over myocardial TSPO, thereby preventing the heart from fatal arrhythmias.
Materials and methods

The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication
No. 85-23, revised 1996) and the policy of Animal Care and Use Committee of the Tongji University. 
Chronic intermittent hypobaric hypoxia model
Adult male Sprague-Dawley (SD) rats (aged 10 weeks, weighing 220-250 g) were separated into two groups. One group (CIHH rats) was exposed to a simulated altitude of 4500-5000 m (barometric pressure 360-380 mmHg) in a well-ventilated, temperature-controlled hypobaric chamber for 14 days for 4 hrs each day (14:00 p.m. ~18:00 p.m.). Upon completing 4 hrs of CIHH, rats were kept in normoxic environments. The control group (normoxic rats) was kept in the same room, but not in the hypobaric chamber, with the same 12-12 hrs light-dark cycle. Free access to a standard rat diet and water was allowed throughout the experimental period.
In vitro global ischaemic VF model
Experimental groups
Hearts were randomly assigned to one of six groups: (1) and (2) 
Quantification of mRNA expression
RNA was extracted and reverse transcribed as previously described [13, 14] 
Results
Following an ischaemic VF inducing protocol, 80% of normoxic rats developed cardiac ischaemic VF, whereas the arrhythmia seldom (16.6%) occurred in the hearts of CIHH rats (Fig. 1) . Stimulation or inhibition of TSPO with FGIN-1-27 or 4Ј-Cl-DZP affected the fatal arrhythmia incidence in normoxic rats. However, FGIN-1-27 could not reverse CIHH-mediated antiarrhythmic effects.
As illustrated in Figure 2A and B, ischaemic VF was positively linked to TSPO activity alterations; specifically, ischaemic VF occurrence accompanied by stepped-up elevation of the protein activity.
Of note, TSPO activity was higher in CIHH rats than in normoxic ones under basal conditions, and was preserved during ischaemia (Fig. 2B and C). Further analysis indicated that ischaemia did not modify the TSPO mRNA expression in normoxic rats. However, the level of TSPO expression was higher in CIHH rats than in normoxic ones under basal conditions, and was preserved throughout ischaemia (Fig. 2D). This evidence strongly supports the idea that CIHH blunts or resets the sensitivity of TSPO to ischaemic stress and further contributes to antiarrhythmia.
Figure 3 showed that [Ca 2ϩ ]i was progressively elevated in normoxic cardiomyocytes during ischaemia, but no significant Ca overload was observed in CIHH cardiomyocytes. Stimulation of TSPO with FGIN-1-FGIN-27 also failed to disrupt intracellular Ca stabilization by CIHH. Inhibition of the protein with 4Ј-Cl-DZP abolished [Ca 2ϩ
]i overload in cardiomyocytes from both normoxic and CIHH rat hearts (Fig. 3B) . In addition, CIHH preserved Ca kinetics including Ca transient decay rate and amplitude during myocardial ischaemia (Fig. 3C and D) , which was consistent with the stabilization of TSPO activity and expression (Fig. 2) .
As indicated in Figure 4A and B, SERCA2a and RyR mRNA expression in normoxic rat hearts were up-regulated during ischaemia; however, they were preserved at a higher level in CIHH rat hearts throughout normal perfusion and ischaemia. CASQ, another important SR Ca-buffering protein, regulates SR Ca release by forming a functional complex with RyR and other SR proteins [15] . Our study demonstrated that the metabolic compromise did not modify the expression of CASQ mRNA (Fig. 4C) [6] . Recently, the relation between abrupt stimulation of TSPO and ischaemia/reperfusion (I/R) ventricular arrhythmias has also been confirmed [9, 10] . In this study, although the TSPO activity was up-regulated by CIHH under basal conditions, it was kept at a similar level during myocardial ischaemia, with the result that VF seldom occurred in CIHH rats. Blunt sensitivity of cardiac TSPO to ischaemic stress by CIHH may confer cardioprotection. These findings further enhanced the point that abrupt and excessive elevation of the TSPO activity contributed to ischaemic VF initiation, although, conversely, preservation of its activity protected the heart from the arrhythmias.
Intermittent hypoxia or CIHH, a model of adaptation to mild hypoxia, has been perceived to enhance the power of stress-limiting systems, mitochondrial oxygen utilization and cardiac tolerance to severe hypoxia, as well as further conferred cardioprotection [16] [17] [18] . As reported here, CIHH conferred resistance to (Fig. 1) . It is known that TSPO is an important sensor to stresses, and that it regulates mitochondrial oxygen utilization [4] . Thus, this finding also supports the notion that TSPO may be an important stress-limiting system in the heart. Intracellular [Ca 2ϩ ]i overload is recognized as the key event in triggering VF and preventing its reversal [1, 19, 20] . In addition, dysfunction of the sarcoplasmic reticulum (SR) calcium release and uptake increases ventricular automaticity and arrhythmia initiation [1, 19] . Previous studies have demonstrated that adaptation to hypoxia protected cardiomyocytes from ischaemia reperfusion [Ca 2ϩ ]i overload [16] [17] [18] . Here 
Fig. 2 Modulations of CIHH on translocator protein (TSPO). (A) Representative binding curves for TSPO in normoxic rat hearts that underwent stressinduced ventricular fibrillation (VF) protocol. (B) Stepwise elevation of Bmax was positively linked to ischaemic VF. CIHH up-regulated and preserved TSPO throughout normal and low-flow perfusion. (CIHH: chronic intermittent hypobaric hypoxia; *P Ͻ 0.05; **P Ͻ 0.01). (C) Regulation of Kd (equilibration dissociation constant) by ischaemia and CIHH (*P Ͻ 0.05). (D) Modification of TSPO mRNA expression by ischaemia and CIHH (*P Ͻ 0.05).
Fig. 3 Translocator protein (TSPO) contributes to [
